Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

350 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 350 results

Early research (Phase 1)Study completedNCT01153607
What this trial is testing

Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers

Who this might be right for
Diagnostic Imaging
Life Molecular Imaging SA 24
Early research (Phase 1)Looking for participantsNCT06479811
What this trial is testing

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Who this might be right for
Head and Neck TumorsKidney CancersSmall Cell Lung Cancers+3 more
National Cancer Institute (NCI) 120
Not applicableStudy completedNCT03002116
What this trial is testing

Microwave Radiometry Thermometry for the Diagnosis of Critical Limb Ischemia in Diabetic Patients

Who this might be right for
Diabetic FootPeripheral Arterial DiseaseIschaemic Neuropathy
Attikon Hospital 80
Early research (Phase 1)Ended earlyNCT05999292
What this trial is testing

Phase 1 Study of 68Ga-R8760

Who this might be right for
Adrenocortical Carcinoma
Radionetics Oncology 11
Not applicableStudy completedNCT05537675
What this trial is testing

Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction

Who this might be right for
Refractory Meningioma
Central Hospital, Nancy, France 20
Testing effectiveness (Phase 2)Ended earlyNCT04467515
What this trial is testing

Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer

Who this might be right for
Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care Treatment
Precirix 13
Early research (Phase 1)Ended earlyNCT01420952
What this trial is testing

Imaging of Brain Receptors Using (11C)mGlu1

Who this might be right for
DosimetryPharmacokinetics
National Institute of Mental Health (NIMH) 3
Not applicableNot Yet RecruitingNCT05832385
What this trial is testing

Effects of Different Radiation Dosimetry for Anorectal Function of Patients With Pelvic Cancer

Who this might be right for
Anorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 124
Early research (Phase 1)Study completedNCT05410821
What this trial is testing

Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer

Who this might be right for
Refractory Thyroid Gland CarcinomaRefractory Thyroid Gland Papillary CarcinomaRefractory Thyroid Gland Follicular Carcinoma+1 more
The First Affiliated Hospital of Xiamen University 12
Very early researchNot Yet RecruitingNCT07420036
What this trial is testing

An Open-label, Single-arm, Single-center Study to Evaluate the Diagnostic Efficacy of a Novel PET Probe, 68Ga-SFB6-ZN01, in Patients With Malignant Tumors

Who this might be right for
Neoplasms
Zhongnan Hospital 98
Testing effectiveness (Phase 2)Study completedNCT00597129
What this trial is testing

Safety and Efficacy Study of 90Y-hPAM4 at Different Doses

Who this might be right for
Pancreatic Cancer
Gilead Sciences 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05896371
What this trial is testing

Personalized PSMA Radiopharmaceutical Therapy

Who this might be right for
CancerProstate CancerMetastatic Cancer+1 more
CHU de Quebec-Universite Laval 500
Early research (Phase 1)Looking for participantsNCT07253753
What this trial is testing

Evaluate Safety and Dosimetry of [18F]4-FDF, a New PET Imaging Agent for Inflammation

Who this might be right for
Healthy
Yellowbird Diagnostics Inc 12
Early research (Phase 1)UnknownNCT03308682
What this trial is testing

177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Peking Union Medical College Hospital 30
Early research (Phase 1)Study completedNCT00673010
What this trial is testing

Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma

Who this might be right for
Thyroid Cancer
Memorial Sloan Kettering Cancer Center 20
Early research (Phase 1)Study completedNCT01089998
What this trial is testing

PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations

Who this might be right for
Diagnostic Imaging
Life Molecular Imaging SA 35
Not applicableEnded earlyNCT02279693
What this trial is testing

Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Centre Georges Francois Leclerc 3
Very early researchNot Yet RecruitingNCT05557708
What this trial is testing

A Safety Study of 212Pb-Pentixather Radioligand Therapy

Who this might be right for
Carcinoid Tumor LungNeuroendocrine Tumor of the LungCarcinoma, Small-Cell Lung
Yusuf Menda 20
Early research (Phase 1)WithdrawnNCT04632199
What this trial is testing

Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer.

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal Cancer
Ipsen
Early research (Phase 1)Looking for participantsNCT06337084
What this trial is testing

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultBladder CancerUrothelial Carcinoma+6 more
Monopar Therapeutics 12
Load More Results